EVANSMED - Evans Medical Plc
Evans Medical Plc is a Nigeria-based company, active in the healthcare industry. The company is engaged in the manufacturing, research, and development of pharmaceutical products. Its portfolio of product includes Multivites, Cofta, Vanclox, Rapidflox, Amovin, and Ferbelan. Evans Medical Plc undertook a restructuring that saw the company metamorphose into four different companies, namely, Evans Medical Plc (which is primarily engaged in manufacturing, sales, and marketing of OTC-Products), Evans Nutraceutical Ventures Limited, CiplaEvans Nigeria Limited, and Evans Healthcare Nigeria Limited. Evans Medical Plc operates a network of 30 pharmacies in Nigeria.
| Last Trading Results | Growth & Valuation | ||
|---|---|---|---|
| Opening Price: | -- | Earnings Per Share: | -- |
| Day's Low Price: | -- | Price/Earning Ratio: | -- |
| Day's High Price: | -- | Dividend Per Share: | -- |
| Traded Volume: | 20,000 | Dividend Yield: | -- |
| Number of Deals: | 1 | Shares Outstanding: | 732.35m |
| Value/Turnover: | 10,000.00 | Market Capitalization: | 366.17m |
Monetary values are quoted in Nigerian Naira (NGN) unless otherwise stated
EVANSMED Market Performance
EVANSMED currently ranks 71st on the Nigerian Stock Exchange in terms of returns to investors with a year-to-date return of zero percent. Following EVANSMED are AFRIPRUD (-0.34%), CAPHOTEL (-0.57%), and INFINITY (-2.04%). Shareholders are anxiously awaiting when Evans Medical Plc will announce dividends to see whether they have gained something or not. Below is the historical trading trend of EVANSMED, covering up to the last 10 trading sessions of activity.
| Date | Volume | Open | Close | Change | %Change |
|---|---|---|---|---|---|
| 2017-06-22 | 41,500 | 0.50 | 0.50 | +0.00 | 0.00% |
| 2017-06-20 | 600 | 0.50 | 0.50 | +0.00 | 0.00% |
| 2017-06-09 | 300 | 0.50 | 0.50 | +0.00 | 0.00% |
| 2017-06-08 | 76 | 0.50 | 0.50 | +0.00 | 0.00% |
| 2017-06-01 | 184 | 0.50 | 0.50 | +0.00 | 0.00% |
| 2017-05-18 | 7,300 | 0.50 | 0.50 | +0.00 | 0.00% |
| 2017-05-17 | 397 | 0.50 | 0.50 | +0.00 | 0.00% |
| 2017-05-11 | 350 | 0.50 | 0.50 | +0.00 | 0.00% |
| 2017-05-03 | 10 | 0.50 | 0.50 | +0.00 | 0.00% |
| 2017-04-10 | 253 | 0.50 | 0.50 | +0.00 | 0.00% |
Profile of Evans Medical Plc
Evans Medical Plc operates in the Health Care sector, specifically, the Pharmaceuticals industry—according to the reverse Industry Classification Benchmark (ICB) taxonomy. The company's board of directors is composed of 10 members whose names are listed below.
- Chief Saifudeen Ademola Edu
Chairman - Chief Olubunmi Olaopa
Group Managing Director - Sola I. Ogunwale
Financial Director - Oyewo Adeoye
Director, Sales & Marketing - Titilope Bamidele Adeyemi (Mrs.)
Director, Quality Assurance - Oyenuga Adewale
MD, Evans Therapeutics Ltd. - Michael Ajufo
Technical Director - Alhaji Ahmad I. Damcida
Director - Odunsi Bolaji
Director - Victor Eburajolo Mni
Director
| Factsheet of Evans Medical Plc | |
|---|---|
| Sector: Health Care | Industry: Pharmaceuticals |
| Address: Plot 6, Abimbola Way, Isolo, Lagos, Nigeria | |
| Telephone: +234-1-790-1401 | Facsimile: +234-1-452-9461 |
| Email: info@evansmedicalplc.com | Website: www.evansmedicalplc.com |
Industrial Stock Market Competitors
Evans Medical Plc, issuers of the EVANSMED stock on the Nigerian Stock Exchange, have seven market competitors who are also engaged in the Health Care/Pharmaceuticals industry. The table below gives you an overview of their market standing.
| Symbol | Company | Mkt. Cap. | Price | Change |
|---|---|---|---|---|
| GLAXOSMITH | Glaxo Smithkline Consumer | 24.46b | 20.45 | +0.00 |
| MAYBAKER | May & Baker Nigeria | 4.65b | 4.74 | -0.24 |
| FIDSON | Fidson Healthcare | 4.13b | 2.75 | -0.10 |
| NEIMETH | Neimeth International Pharma | 1.69b | 0.98 | +0.06 |
| NIG-GERMAN | Nigeria-German Chemicals | 556.71m | 3.62 | +0.00 |
| PHARMDEKO | Pharma-Deko Plc | 487.85m | 2.25 | +0.07 |
| AFRIK | Afrik Pharmaceuticals | 12.45m | 0.50 | +0.00 |